Walleye Capital’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
Other funds holding BCYC
BBA
LFCM
Walleye Capital's BCYC Position: Q3 2026 in Review
Walleye Capital sold out of Bicycle Therapeutics (BCYC) in Q3 2026, closing a stake of 13,000 shares — an estimated $52.6K sold.
Walleye Capital first reported a position in BCYC in Q4 2023 and held it in 4 quarters. The position peaked at $2.71M in Q4 2023. 90 funds tracked by Wall St. Rank hold BCYC as of Q3 2026.
- Walleye Capital reported no remaining Bicycle Therapeutics position as of Q3 2026 after selling out during the quarter.
- Walleye Capital sold 13,000 Bicycle Therapeutics shares in Q3 2026, an estimated $52.6K.
- Walleye Capital first reported a position in Bicycle Therapeutics in Q4 2023 and held it in 4 quarters.
- Walleye Capital's Bicycle Therapeutics position peaked at $2.71M in Q4 2023.
- 90 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.